NextenBio Completes Acquisition of Mirae Industry, a KOSPI Semiconductor Equipment Company

Nexen BioScience announced on the 22nd that it has completed the acquisition contract by completing the payment of 10 billion KRW in convertible bonds (CB) to Mirae Industry, a KOSPI-listed company.

Nexen BioScience paid a deposit of 8 billion KRW through the main contract to purchase Mirae Industry common stocks on May 23, and on July 12, paid the remaining 16.5 billion KRW to secure a 9.55% stake, becoming the largest shareholder.

At today's acquisition contract, Nexen BioScience also paid for the 8th series convertible bonds worth 10 billion KRW issued by Mirae Industry, finalizing the acquisition contract for Mirae Industry at a total of 34.5 billion KRW, and will be able to strengthen its stake upon future CB conversion.

Mirae Industry, a KOSPI-listed company established in 1983, is a specialized semiconductor equipment manufacturer. Its main business divisions are tester handler production ATE and chip mounter production SMT, with major clients including SK Hynix and China's YMTC.

The 'tester handler' is a semiconductor post-process inspection equipment that supplies semiconductor chips, which have completed all processes on the wafer, to the main inspection equipment, sorting good and defective products. High growth is expected due to the surge in semiconductor demand driven by the growth of AI, big data, the Internet of Things, and autonomous vehicle markets.

The 'chip mounter' is equipment that automatically assembles various electronic components such as semiconductor chips onto electronic circuit boards. It has continued to grow alongside the expansion of major markets such as displays, smartphones, TVs, automotive electronics, and LEDs.

Nexen BioScience, which acquired Mirae Industry, is a specialized manufacturer of CNC automatic lathes, developing and producing customized automatic lathes based on a diverse product lineup.

Additionally, through continuous investment activities, it is building broad business diversification, and together with Mirae Industry and EV Advanced Materials acquired in 2021, it now has two listed companies as subsidiaries.

A Nexen BioScience official stated, “This year, we will do our best to improve profitability through company restructuring, continuously enhance business capabilities, and foster mutual growth through cooperation among affiliates.”